Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Autor: Ralph A. H. Stewart, Claes Held, Sue Krug‐Gourley, Dawn Waterworth, Amanda Stebbins, Karen Chiswell, Emil Hagstrom, Paul W. Armstrong, Lars Wallentin, Harvey White

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 7 (2019)

Background Vascular risk factors have been associated with differences in cognitive performance in epidemiological studies, but evidence in patients with coronary heart disease is more limited. Methods and Results The Montreal Cognitive Assessment sc

Externí odkaz: https://doaj.org/article/0867d6f57a9d49588b04100e233f20fe

Corrigendum to '2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk' [Atherosclerosis 290 (2019) 140–205]

Autor: Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Djamaleddine Nibouche, Parounak H. Zelveian, Peter Siostrzonek, Ruslan Najafov, Philippe van de Borne, Belma Pojskic, Arman Postadzhiyan, Lambros Kypris, Jindřich Špinar, Mogens Lytken Larsen, Hesham Salah Eldin, Margus Viigimaa, Timo E. Strandberg, Jean Ferrieres, Rusudan Agladze, Ulrich Laufs, Loukianos Rallidis, Laszlo Bajnok, Thorbjorn Gudjonsson, Vincent Maher, Yaakov Henkin, Michele Massimo Gulizia, Aisulu Mussagaliyeva, Gani Bajraktari, Alina Kerimkulova, Gustavs Latkovskis, Omar Hamoui, Rimvydas Slapikas, Laurent Visser, Philip Dingli, Victoria Ivanov, Aneta Boskovic, Mbarek Nazzi, Frank Visseren, Irena Mitevska, Kjetil Retterstol, Piotr Jankowski, Ricardo Fontes-Carvalho, Dan Gaita, Marat Ezhov, Marina Foscoli, Vojislav Giga, Daniel Pella, Zlatko Fras, Leopoldo Perez de Isla, Emil Hagstrom, Roger Lehmann, Leila Abid, Oner Ozdogan, Olena Mitchenko, Riyaz S. Patel, Stephan Windecker, Victor Aboyans, Jean-Philippe Collet, Veronica Dean, Donna Fitzsimons, Chris P. Gale, Diederick Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Juni, Hugo A. Katus, Christophe Leclercq, Maddalena Lettino, Basil S. Lewis, Bela Merkely, Christian Mueller, Steffen Petersen, Anna Sonia Petronio, Marco Roffi, Evgeny Shlyakhto, Iain A. Simpson, Miguel Sousa-Uva, Rhian M. Touyz

Publikováno v: Atherosclerosis. 294:80-82

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c72affa5ddb1e34812022629966be6b
https://doi.org/10.1016/j.atherosclerosis.2019.12.004

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes

Autor: Stefan James, Shaun G. Goodman, Megan L. Neely, Raffaele De Caterina, Freek W.A. Verheugt, Danny Liaw, Daniel M. Wojdyla, Renato D. Lopes, Basil S. Lewis, Deepak L. Bhatt, Connie N. Hess, John H. Alexander, Hisao Ogawa, Emil Hagstrom, Lars Wallentin, Steen Husted

Publikováno v: Journal of the American College of Cardiology. 66:777-787

Background: Bleeding limits anticoagulant treatment in patients with acute coronary syndromes (ACS).Objectives: We investigated whether background concomitant antiplatelet therapy influence...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d702c5702f4437828ebde93de18c220d
https://doi.org/10.1016/j.jacc.2015.06.027

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial

Autor: Connie N, Hess, Stefan, James, Renato D, Lopes, Daniel M, Wojdyla, Megan L, Neely, Danny, Liaw, Emil, Hagstrom, Deepak L, Bhatt, Steen, Husted, Shaun G, Goodman, Basil S, Lewis, Freek W A, Verheugt, Raffaele, De Caterina, Hisao, Ogawa, Lars, Wallentin, John H, Alexander

Publikováno v: Journal of the American College of Cardiology. 66(7)

Bleeding limits anticoagulant treatment in patients with acute coronary syndromes (ACS).We investigated whether background concomitant antiplatelet therapy influences the effects of apixaban after ACS.This study examined high-risk ACS patients who we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d2fdda0ab5adef20d775ea54be699ae2
https://pubmed.ncbi.nlm.nih.gov/26271060

Studies from Linkoping University Further Understanding of Heart Attack (Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden).

Publikováno v: Cardiovascular Week; 2024, p971-971, 1p